Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Children With Juvenile Rheumatoid Arthritis
NCT03780959Phase 3Completed
- Sponsor
- Amgen
- Start
- May 1997
- Primary completion
- Jul 1998
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in juvenile idiopathic arthritis (JIA), sponsored by Amgen. Started May 1997; status: completed.
02
Drugs
etanercept
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT03780959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03780959.